ICU Medical
Market Cap
US$4.3b
Last Updated
2021/03/04 00:04 UTC
Data Sources
Company Financials +
Executive Summary
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in vascular therapy and critical care applications worldwide. More Details
Snowflake Analysis
Flawless balance sheet with moderate growth potential.
Similar Companies
Share Price & News
How has ICU Medical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ICUI is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: ICUI's weekly volatility (4%) has been stable over the past year.
Market Performance
7 Day Return
-7.6%
ICUI
-3.1%
US Medical Equipment
-3.4%
US Market
1 Year Return
2.2%
ICUI
28.0%
US Medical Equipment
29.4%
US Market
Return vs Industry: ICUI underperformed the US Medical Equipment industry which returned 28% over the past year.
Return vs Market: ICUI underperformed the US Market which returned 29.4% over the past year.
Shareholder returns
| ICUI | Industry | Market | |
|---|---|---|---|
| 7 Day | -7.6% | -3.1% | -3.4% |
| 30 Day | -0.2% | -1.5% | 0.6% |
| 90 Day | 4.6% | 5.0% | 6.3% |
| 1 Year | 2.2%2.2% | 29.0%28.0% | 32.2%29.4% |
| 3 Year | -21.0%-21.0% | 69.2%65.1% | 51.3%41.7% |
| 5 Year | 120.9%120.9% | 151.7%133.8% | 119.6%95.2% |
Long-Term Price Volatility Vs. Market
How volatile is ICU Medical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Did ICU Medical, Inc. (NASDAQ:ICUI) Insiders Sell Shares?1 month ago | Simply Wall St
If You Had Bought ICU Medical (NASDAQ:ICUI) Stock Five Years Ago, You Could Pocket A 134% Gain Today1 month ago | Simply Wall St
Will ICU Medical (NASDAQ:ICUI) Multiply In Value Going Forward?Valuation
Is ICU Medical undervalued compared to its fair value and its price relative to the market?
48.83x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: ICUI ($202.9) is trading above our estimate of fair value ($110.72)
Significantly Below Fair Value: ICUI is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: ICUI is good value based on its PE Ratio (48.8x) compared to the US Medical Equipment industry average (51.7x).
PE vs Market: ICUI is poor value based on its PE Ratio (48.8x) compared to the US market (21.4x).
Price to Earnings Growth Ratio
PEG Ratio: ICUI is poor value based on its PEG Ratio (1.9x)
Price to Book Ratio
PB vs Industry: ICUI is good value based on its PB Ratio (2.8x) compared to the US Medical Equipment industry average (5.2x).
Next Steps
Future Growth
How is ICU Medical forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
26.3%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ICUI's forecast earnings growth (26.3% per year) is above the savings rate (2%).
Earnings vs Market: ICUI's earnings (26.3% per year) are forecast to grow faster than the US market (19.6% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ICUI's revenue (0.8% per year) is forecast to grow slower than the US market (10.1% per year).
High Growth Revenue: ICUI's revenue (0.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ICUI's Return on Equity is forecast to be low in 3 years time (10%).
Next Steps
Past Performance
How has ICU Medical performed over the past 5 years?
9.9%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ICUI has a large one-off loss of $41.8M impacting its December 31 2020 financial results.
Growing Profit Margin: ICUI's current net profit margins (6.8%) are lower than last year (8%).
Past Earnings Growth Analysis
Earnings Trend: ICUI's earnings have grown by 9.9% per year over the past 5 years.
Accelerating Growth: ICUI's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ICUI had negative earnings growth (-13.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (9.8%).
Return on Equity
High ROE: ICUI's Return on Equity (5.8%) is considered low.
Next Steps
Financial Health
How is ICU Medical's financial position?
Financial Position Analysis
Short Term Liabilities: ICUI's short term assets ($920.8M) exceed its short term liabilities ($195.5M).
Long Term Liabilities: ICUI's short term assets ($920.8M) exceed its long term liabilities ($65.9M).
Debt to Equity History and Analysis
Debt Level: ICUI is debt free.
Reducing Debt: ICUI had no debt 5 years ago.
Debt Coverage: ICUI has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: ICUI has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Next Steps
Dividend
What is ICU Medical current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ICUI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ICUI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ICUI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ICUI's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ICUI's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
3.2yrs
Average management tenure
CEO
Vivek Jain (48 yo)
7.08yrs
Tenure
US$2,825,277
Compensation
Mr. Vivek Jain has been an Independent Director of Envista Holdings Corporation since April 7, 2020. Mr. Jain has been Chairman and Chief Executive Officer of ICU Medical, Inc. since February 13, 2014. Mr....
CEO Compensation Analysis
Compensation vs Market: Vivek's total compensation ($USD2.83M) is below average for companies of similar size in the US market ($USD4.96M).
Compensation vs Earnings: Vivek's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 7.08yrs | US$2.83m | 0.33% $ 14.2m | |
| Chief Operating Officer | 3.17yrs | US$2.50m | 0.043% $ 1.8m | |
| Corporate VP | 3.17yrs | US$1.40m | 0.0092% $ 395.4k | |
| CFO & Treasurer | 1yr | no data | 0.0043% $ 186.1k | |
| Chief Accounting Officer | no data | no data | 0.011% $ 473.1k |
3.2yrs
Average Tenure
47yo
Average Age
Experienced Management: ICUI's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 7.08yrs | US$2.83m | 0.33% $ 14.2m | |
| Independent Director | 5.17yrs | US$267.01k | 0.0070% $ 301.1k | |
| Director | 37.17yrs | US$368.40k | 5.81% $ 249.0m | |
| Independent Director | 23.17yrs | US$257.51k | 0.12% $ 5.1m | |
| Independent Director | 3.17yrs | US$240.01k | 0.0033% $ 140.7k | |
| Lead Independent Director | no data | US$278.51k | 0.015% $ 649.8k | |
| Independent Director | 3.17yrs | US$240.01k | 0.0033% $ 140.7k |
6.1yrs
Average Tenure
59yo
Average Age
Experienced Board: ICUI's board of directors are considered experienced (6.1 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: ICUI insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
ICU Medical, Inc.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: ICU Medical, Inc.
- Ticker: ICUI
- Exchange: NasdaqGS
- Founded: 1984
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: US$4.289b
- Shares outstanding: 21.14m
- Website: https://www.icumed.com
Number of Employees
Location
- ICU Medical, Inc.
- 951 Calle Amanecer
- San Clemente
- California
- 92673
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| ICUI | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Mar 1992 |
| IC7 | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Mar 1992 |
Biography
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in vascular therapy and critical care applications worldwide. The company’s infusion therapy produc...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/03/04 00:04 |
| End of Day Share Price | 2021/03/03 00:00 |
| Earnings | 2020/12/31 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.